News FDA approves diabetic foot ulcer shock wave device The US regulator has approved the first ever shock wave wound healing device, for use in patients with diabetic foot ulcers.
News Despite study bust, Vistagen still hopes to file anxiety dru... Vistagen has chalked up another trial failure for fasedienol, its drug candidate for social anxiety disorder.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.